AmpliPhi Biosciences (NYSEMKT:APHB) prices its public offering of 16,537,500 shares of common stock and warrants to purchase up to 16,537,500 common shares and pre-funded warrants at a combined price of $0.40.
Underwriters over-allotment is an additional 2,480,625 shares of common stock and/or common warrants.
The net proceeds of ~$6.2M will ve used for general corporate purposes, including manufacturing, R&D and G&A expenses.
Closing date is October 16.
Shares are down 34% premarket.
Subscribe for full text news in your inbox